ArticleBMC cardiovascular disorders2024

Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study.

Yue Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.